Concord Biotech Ltd (CONCORDBIO) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 10038977, "name": "Concord Biotech", "stock_name": "Concord Biotech", "full_name": "Concord Biotech Ltd", "name_url": "stocks-analysis/concord-biotech", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "1,175.15", "chg": -22, "chgp": "-1.84%", "dir": -1, "prev_price": "1,197.15", "mcapval": "12,371.00 Cr", "mcap": "Small Cap", "scripcode": 543960, "symbol": "CONCORDBIO", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "India SENSEX", "isin": "INE338H01029", "curr_date": "May 08", "curr_time": "", "bse_nse_vol": "1.62 lacs", "exc_status": "Active", "traded_date": "May 08, 2026", "traded_date_str": "2026 05 08", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/concord-biotech-10038977-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Concord Biotech Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/concord-biotech-ltd-is-rated-sell-3981471", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ConcordBiotechL_mojoScore_3981471.png", "date": "2026-05-08 10:10:22", "description": "Concord Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 24 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 May 2026, providing investors with an up-to-date view of its fundamentals, returns, and market standing." }, { "title": "Concord Biotech Ltd Technical Momentum Shifts Amid Mixed Market Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/concord-biotech-ltd-technical-momentum-shifts-amid-mixed-market-signals-3978982", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ConcordBiotechL_technicaldot_3978982.png", "date": "2026-05-07 08:06:41", "description": "Concord Biotech Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in price momentum and technical indicators, signalling a transition from a mildly bearish trend to a sideways movement. Despite a robust day gain of 3.24%, the stock’s technical landscape presents a complex picture, with mixed signals from MACD, RSI, moving averages, and other key indicators." }, { "title": "Concord Biotech Gains 12.24%: 3 Key Factors Driving the Weekly Rally", "link": "https://www.marketsmojo.com/news/stocks-in-action/concord-biotech-gains-1224-3-key-factors-driving-the-weekly-rally-3971411", "imagepath": "", "date": "2026-05-02 11:00:47", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>27 Apr:</strong> Downgrade to Sell amid mixed technicals and weak financials</p>\n <p><strong>27 Apr:</strong> Technical momentum shifts from strongly bearish to mildly bearish</p>\n <p><strong>29 Apr:</strong> Intraday high of Rs.1,152.3 with a 7.12% surge</p>\n <p><strong>30 Apr:</strong> Week closes at Rs.1,140.15, up 12.24% for the week</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,015.85</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=..." }, { "title": "Concord Biotech Ltd Surges 7.12% to Day's High of Rs 1152.3 — Outperforms Sector by 7.02 Percentage Points", "link": "https://www.marketsmojo.com/news/stocks-in-action/concord-biotech-ltd-hits-intraday-high-with-712-surge-on-29-apr-2026-3968310", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ConcordBiotechL_priceRelatedfactors_3968310.png", "date": "2026-04-29 11:16:01", "description": "The Sensex climbed 1.25% on 29 Apr 2026, yet Concord Biotech Ltd outpaced both the benchmark and its sector with a robust 7.12% gain, touching an intraday high of Rs 1152.3. That 7.02-percentage-point outperformance signals a distinctly stock-specific rally rather than a mere market tailwind." }, { "title": "Concord Biotech Ltd Downgraded to Sell Amid Mixed Technicals and Weak Financials", "link": "https://www.marketsmojo.com/news/stock-recommendation/concord-biotech-ltd-downgraded-to-sell-amid-mixed-technicals-and-weak-financials-3963780", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ConcordBiotechL_mojoScore_3963780.png", "date": "2026-04-27 08:15:40", "description": "Concord Biotech Ltd’s investment rating has been upgraded from Strong Sell to Sell as of 24 April 2026, reflecting nuanced shifts across technical indicators and financial performance metrics. Despite persistent challenges in profitability and valuation concerns, improvements in technical trends and management efficiency have moderated the outlook, prompting a recalibration of the stock’s rating within the Pharmaceuticals & Biotechnology sector." }, { "title": "Concord Biotech Ltd Technical Momentum Shifts Amid Prolonged Downtrend", "link": "https://www.marketsmojo.com/news/stocks-in-action/concord-biotech-ltd-technical-momentum-shifts-amid-prolonged-downtrend-3963720", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ConcordBiotechL_technicaldot_3963720.png", "date": "2026-04-27 08:02:53", "description": "Concord Biotech Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a subtle shift in its technical momentum, moving from a strongly bearish stance to a mildly bearish outlook. Despite this slight improvement, the stock continues to face significant downward pressure, reflected in its recent price action and technical indicators." }, { "title": "Concord Biotech Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/concord-biotech-ltd-is-rated-sell-3962153", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ConcordBiotechL_mojoScore_3962153.png", "date": "2026-04-25 10:10:25", "description": "Concord Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 24 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 April 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance." }, { "title": "Concord Biotech Ltd Faces Bearish Momentum Amid Technical Downturn", "link": "https://www.marketsmojo.com/news/stocks-in-action/concord-biotech-ltd-faces-bearish-momentum-amid-technical-downturn-3955183", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ConcordBiotechL_technicaldot_3955183.png", "date": "2026-04-21 08:06:41", "description": "Concord Biotech Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more pronounced bearish trend. This transition is underscored by deteriorating technical indicators including MACD, moving averages, and Bollinger Bands, signalling increased selling pressure and subdued investor sentiment." }, { "title": "Concord Biotech Gains 1.82% Despite Strong Sell Downgrade: 4 Key Factors Driving the Week", "link": "https://www.marketsmojo.com/news/stocks-in-action/concord-biotech-gains-182-despite-strong-sell-downgrade-4-key-factors-driving-the-week-3952159", "imagepath": "", "date": "2026-04-18 11:00:05", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>13 Apr:</strong> Downgrade to Strong Sell rating announced</p>\n <p><strong>15 Apr:</strong> Technical indicators signal intensified bearish momentum</p>\n <p><strong>17 Apr:</strong> Stock rebounds sharply, closing at Rs.1,081.25 (+4.13%)</p>\n <p><strong>Weekly Summary:</strong> Stock gains 1.82% vs Sensex +2.33%</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,061.90</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.1,081.25</..." } ], "total": 402, "sid": "10038977", "stock_news_url": "https://www.marketsmojo.com/news/concord-biotech-10038977" }, "announcements": [ { "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018", "datetime": "08-Apr-2026", "details": "Certificate under regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 for the quarter ended March 31 2026 as received from RTA of the Company.", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Updates on Acquisition", "datetime": "02-Apr-2026", "details": "In Continuation to our intimation dated November 13 2025 we are pleased to announce Investment in Celliimune Biotech Private Limited.", "source": "BSE" }, { "caption": "Closure of Trading Window", "datetime": "27-Mar-2026", "details": "The trading window for trading in the Equity Shares by the Designated Persons of the Company will be closed from 1st April 2026 till the expiry of 48 hours after the declaration of the Audited Financial Results for the quarter and year ended on 31st March 2026.", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Concord Biotech Ltd has declared <strong>1070%</strong> dividend, ex-date: 03 Sep 25", "dt": "2025-09-03", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

27 Apr: Downgrade to Sell amid mixed technicals and weak financials

27 Apr: Technical momentum shifts from strongly bearish to mildly bearish

29 Apr: Intraday high of Rs.1,152.3 with a 7.12% surge

30 Apr: Week closes at Rs.1,140.15, up 12.24% for the week

Week Open

Rs.1,015.85

Week Close

Read full news article

Concord Biotech Ltd Surges 7.12% to Day's High of Rs 1152.3 — Outperforms Sector by 7.02 Percentage Points

2026-04-29 11:16:01

The Sensex climbed 1.25% on 29 Apr 2026, yet Concord Biotech Ltd outpaced both the benchmark and its sector with a robust 7.12% gain, touching an intraday high of Rs 1152.3. That 7.02-percentage-point outperformance signals a distinctly stock-specific rally rather than a mere market tailwind.

Read full news article

Concord Biotech Ltd Downgraded to Sell Amid Mixed Technicals and Weak Financials

2026-04-27 08:15:40

Concord Biotech Ltd’s investment rating has been upgraded from Strong Sell to Sell as of 24 April 2026, reflecting nuanced shifts across technical indicators and financial performance metrics. Despite persistent challenges in profitability and valuation concerns, improvements in technical trends and management efficiency have moderated the outlook, prompting a recalibration of the stock’s rating within the Pharmaceuticals & Biotechnology sector.

Read full news article

Concord Biotech Ltd Technical Momentum Shifts Amid Prolonged Downtrend

2026-04-27 08:02:53

Concord Biotech Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a subtle shift in its technical momentum, moving from a strongly bearish stance to a mildly bearish outlook. Despite this slight improvement, the stock continues to face significant downward pressure, reflected in its recent price action and technical indicators.

Read full news article

Concord Biotech Ltd is Rated Sell

2026-04-25 10:10:25

Concord Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 24 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 April 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Concord Biotech Ltd Faces Bearish Momentum Amid Technical Downturn

2026-04-21 08:06:41

Concord Biotech Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more pronounced bearish trend. This transition is underscored by deteriorating technical indicators including MACD, moving averages, and Bollinger Bands, signalling increased selling pressure and subdued investor sentiment.